J&J Slammed With $8B Verdict In Philly Risperdal Case
A Philadelphia jury hammered a Johnson & Johnson unit with an $8 billion punitive damages verdict on Tuesday after agreeing the company had recklessly ignored the risks that the antipsychotic drug...To view the full article, register now.
Already a subscriber? Click here to view full article